28335379|t|The Role of Adenosine Signaling in Headache: A Review.
28335379|a|Migraine is the third most prevalent disease on the planet, yet our understanding of its mechanisms and pathophysiology is surprisingly incomplete. Recent studies have built upon decades of evidence that adenosine, a purine nucleoside that can act as a neuromodulator, is involved in pain transmission and sensitization. Clinical evidence and rodent studies have suggested that adenosine signaling also plays a critical role in migraine headache. This is further supported by the widespread use of caffeine, an adenosine receptor antagonist, in several headache treatments. In this review, we highlight evidence that supports the involvement of adenosine signaling in different forms of headache, headache triggers, and basic headache physiology. This evidence supports adenosine A2A receptors as a critical adenosine receptor subtype involved in headache pain. Adenosine A2A receptor signaling may contribute to headache via the modulation of intracellular Cyclic adenosine monophosphate (cAMP) production or 5' AMP-activated protein kinase (AMPK) activity in neurons and glia to affect glutamatergic synaptic transmission within the brainstem. This evidence supports the further study of adenosine signaling in headache and potentially illuminates it as a novel therapeutic target for migraine.
28335379	12	21	Adenosine	Chemical	MESH:D000241
28335379	35	43	Headache	Disease	MESH:D006261
28335379	55	63	Migraine	Disease	MESH:D008881
28335379	259	268	adenosine	Chemical	MESH:D000241
28335379	272	289	purine nucleoside	Chemical	MESH:D011684
28335379	339	343	pain	Disease	MESH:D010146
28335379	433	442	adenosine	Chemical	MESH:D000241
28335379	483	500	migraine headache	Disease	MESH:D008881
28335379	553	561	caffeine	Chemical	MESH:D002110
28335379	608	616	headache	Disease	MESH:D006261
28335379	700	709	adenosine	Chemical	MESH:D000241
28335379	742	750	headache	Disease	MESH:D006261
28335379	752	760	headache	Disease	MESH:D006261
28335379	781	789	headache	Disease	MESH:D006261
28335379	835	838	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;CorrespondingGene:5563;CorrespondingSpecies:9606
28335379	902	915	headache pain	Disease	MESH:D010146
28335379	930	939	 receptor	Gene	135
28335379	927	930	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;CorrespondingGene:5563;CorrespondingSpecies:9606
28335379	968	976	headache	Disease	MESH:D006261
28335379	1013	1043	Cyclic adenosine monophosphate	Chemical	MESH:D000242
28335379	1045	1049	cAMP	Chemical	MESH:D000242
28335379	1098	1102	AMPK	Gene	5563
28335379	1245	1254	adenosine	Chemical	MESH:D000241
28335379	1268	1276	headache	Disease	MESH:D006261
28335379	1342	1350	migraine	Disease	MESH:D008881
28335379	Association	MESH:D000242	HGVS:c.2A>A;CorrespondingGene:5563
28335379	Association	HGVS:c.2A>A;CorrespondingGene:5563	MESH:D006261
28335379	Association	HGVS:c.2A>A;CorrespondingGene:5563	MESH:D008881
28335379	Association	135	5563
28335379	Association	MESH:D006261	5563
28335379	Association	MESH:D000241	MESH:D008881
28335379	Association	MESH:D011684	MESH:D010146
28335379	Association	MESH:D000241	MESH:D006261
28335379	Association	HGVS:c.2A>A;CorrespondingGene:5563	MESH:D010146
28335379	Negative_Correlation	MESH:D002110	MESH:D006261
28335379	Association	MESH:D000242	135
28335379	Association	MESH:D000242	MESH:D006261
28335379	Association	MESH:D006261	135
28335379	Association	MESH:D000241	MESH:D010146
28335379	Association	MESH:D006261	5563
28335379	Association	MESH:D008881	5563
28335379	Association	MESH:D010146	5563

